Results 111 to 120 of about 91,813 (297)
Hormone therapy for first-line management of menopausal symptoms: Practical recommendations
Hormone therapy use has undergone dramatic changes over the past 20 years. Widespread use of hormone therapy in the 1980s and 1990s came to an abrupt halt in the early 2000s after initial findings of the Women’s Health Initiative trial were published and
Santiago Palacios +4 more
doaj +1 more source
Estrogens promote misfolded proinsulin degradation to protect insulin production and delay diabetes [PDF]
Summary: Conjugated estrogens (CE) delay the onset of type 2 diabetes (T2D) in postmenopausal women, but the mechanism is unclear. In T2D, the endoplasmic reticulum (ER) fails to promote proinsulin folding and, in failing to do so, promotes ER stress and
Allard, Camille +12 more
core +2 more sources
What's New? Cancers of the breast and female genital tract represent more than half of all cancers in women in sub‐Saharan Africa. Here, the authors assessed incidence trends in a female population living in urban sub‐Saharan Africa based on the Zimbabwe National Cancer Registry in Harare over a 30‐year period.
Eric Chokunonga +7 more
wiley +1 more source
Vascular function and cardiovascular risk factors in women with severe flushing [PDF]
Background: Seventy per cent of postmenopausal women suffer from hot flushes causing significant morbidity in 25%. Oestrogen replacement provides symptom relief, but its use has declined following safety issues and there is, as yet, no good alternative ...
Andrikoula +28 more
core +1 more source
Over a dozen cancers have been associated with excess body mass index, primarily in mid‐to‐late adulthood. Whether obesity‐related cancer risk differs across adulthood remains unclear. Using the Sensitive Periods Model and super‐landmarking approaches, this study found that higher BMI increased obesity‐related cancer risk across ages 30–65.
Nadin K. Hawwash +13 more
wiley +1 more source
The hormone therapy remains the most effective method for treating of the vasomotor symptoms and genitourinary syndrome in menopause. The evidence available to date suggests that for women younger than 60 and with a postmenopause no more than 10 years ...
С. О. Шурпяк
doaj +1 more source
An early first pregnancy is protective against postmenopausal breast cancer. However, pregnancy is also a key contributor to weight gain, and adult weight gain increases postmenopausal breast cancer risk. This prospective cohort study quantified the combined effect of adult weight gain and age at first pregnancy on postmenopausal breast cancer risk ...
Lee Malcomson +7 more
wiley +1 more source
Neoadjuvant endocrine therapy (NET) can help prevent metastases and improve survival in patients with hormone receptor‐positive (HR+) breast cancer. Identifying which HR+ patients will benefit from NET, however, remains challenging. Here, in a patient cohort in the Netherlands, the authors evaluated tumor‐stroma ratio (TSR) and magnetic resonance ...
Layla Andour +8 more
wiley +1 more source
Purpose: Hormone receptor-positive breast cancer survivors undergoing endocrine therapy face significant body image challenges. This study aimed to examine differences in body image between hormone receptor-positive breast cancer survivors receiving ...
Oshri Saar Sheffi +4 more
doaj +1 more source
The choice of hormonal and alternative therapy in menopausal and post-menopausal period [PDF]
The choice of hormonal and alternative therapy in menopausal and post-menopausal period Kuznetsova I.V. First Moscow State Medical University named after I.M.Sechenov (Sechenov University), Moscow Menopause is a key moment in the aging of a female
Kuznetsova I.V.
doaj

